Printed From BioPortfolio.com
Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors
07:51 EST 14 Feb 2018 | Labiotech.eu
A collaboration between Bicycle Therapeutics and Cancer Research UK has yielded its first peptide to enter clinical trials for solid tumors. Bicycle Therapeutics, the pioneer of the bicyclic peptide platform, has dosed the first patient in a Phase I/IIa trial ...
This awesome article Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)
Original Article: Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors
